Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;33(12):1155-1177.
doi: 10.1002/da.22572. Epub 2016 Oct 24.

Cross-national Epidemiology of Panic Disorder and Panic Attacks in the World Mental Health Surveys

Affiliations
Free PMC article

Cross-national Epidemiology of Panic Disorder and Panic Attacks in the World Mental Health Surveys

Peter de Jonge et al. Depress Anxiety. .
Free PMC article

Abstract

Context: The scarcity of cross-national reports and the changes in Diagnostic and Statistical Manual version 5 (DSM-5) regarding panic disorder (PD) and panic attacks (PAs) call for new epidemiological data on PD and PAs and its subtypes in the general population.

Objective: To present representative data about the cross-national epidemiology of PD and PAs in accordance with DSM-5 definitions.

Design and setting: Nationally representative cross-sectional surveys using the World Health Organization Composite International Diagnostic Interview version 3.0.

Participants: Respondents (n = 142,949) from 25 high, middle, and lower-middle income countries across the world aged 18 years or older.

Main outcome measures: PD and presence of single and recurrent PAs.

Results: Lifetime prevalence of PAs was 13.2% (SE 0.1%). Among persons that ever had a PA, the majority had recurrent PAs (66.5%; SE 0.5%), while only 12.8% fulfilled DSM-5 criteria for PD. Recurrent PAs were associated with a subsequent onset of a variety of mental disorders (OR 2.0; 95% CI 1.8-2.2) and their course (OR 1.3; 95% CI 1.2-2.4) whereas single PAs were not (OR 1.1; 95% CI 0.9-1.3 and OR 0.7; 95% CI 0.6-0.8). Cross-national lifetime prevalence estimates were 1.7% (SE 0.0%) for PD with a median age of onset of 32 (IQR 20-47). Some 80.4% of persons with lifetime PD had a lifetime comorbid mental disorder.

Conclusions: We extended previous epidemiological data to a cross-national context. The presence of recurrent PAs in particular is associated with subsequent onset and course of mental disorders beyond agoraphobia and PD, and might serve as a generic risk marker for psychopathology.

Keywords: anxiety/anxiety disorders; assessment/diagnosis; epidemiology; international; panic attacks/agoraphobia.

Similar articles

See all similar articles

Cited by 9 articles

  • The Neurobiology of Panic: A Chronic Stress Disorder.
    Goddard AW. Goddard AW. Chronic Stress (Thousand Oaks). 2017 Nov 10;1:2470547017736038. doi: 10.1177/2470547017736038. eCollection 2017 Jan-Dec. Chronic Stress (Thousand Oaks). 2017. PMID: 32440580 Free PMC article. Review.
  • A mobile application for panic disorder and agoraphobia: Insights from a multi-methods feasibility study.
    Ebenfeld L, Kleine Stegemann S, Lehr D, Ebert DD, Funk B, Riper H, Berking M. Ebenfeld L, et al. Internet Interv. 2019 Nov 25;19:100296. doi: 10.1016/j.invent.2019.100296. eCollection 2020 Mar. Internet Interv. 2019. PMID: 31890640 Free PMC article.
  • Sex differences in fear extinction.
    Velasco ER, Florido A, Milad MR, Andero R. Velasco ER, et al. Neurosci Biobehav Rev. 2019 Aug;103:81-108. doi: 10.1016/j.neubiorev.2019.05.020. Epub 2019 May 23. Neurosci Biobehav Rev. 2019. PMID: 31129235 Review.
  • Benzodiazepines versus placebo for panic disorder in adults.
    Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies SJ, Furukawa TA, Koesters M. Breilmann J, et al. Cochrane Database Syst Rev. 2019 Mar 28;3(3):CD010677. doi: 10.1002/14651858.CD010677.pub2. Cochrane Database Syst Rev. 2019. PMID: 30921478 Free PMC article.
  • A comparison of DSM-5 and DSM-IV agoraphobia in the World Mental Health Surveys.
    Roest AM, de Vries YA, Lim CCW, Wittchen HU, Stein DJ, Adamowski T, Al-Hamzawi A, Bromet EJ, Viana MC, de Girolamo G, Demyttenaere K, Florescu S, Gureje O, Haro JM, Hu C, Karam EG, Caldas-de-Almeida JM, Kawakami N, Lépine JP, Levinson D, Medina-Mora ME, Navarro-Mateu F, O'Neill S, Piazza M, Posada-Villa JA, Slade T, Torres Y, Kessler RC, Scott KM, de Jonge P; WHO World Mental Health Survey Collaborators. Roest AM, et al. Version 2. Depress Anxiety. 2019 Jun;36(6):499-510. doi: 10.1002/da.22885. Epub 2019 Feb 6. Depress Anxiety. 2019. PMID: 30726581 Free PMC article.
See all "Cited by" articles

MeSH terms

Feedback